Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD)

Behavioural Brain Research

Volumn 226, Issue 1, 2012, Pages 8-17

  Chelaru, Mircea I ^a   Yang, Pamela B ^a,b   Dafny, Nachum ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Locomotor activity; Open field activity; Ritalin; SHR; WKY and SD rats

Indexed keywords

METHYLPHENIDATE; SODIUM CHLORIDE;

ACUTE DRUG ADMINISTRATION; ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG TOLERANCE; FEMALE; HORMONE RESPONSE; LOCOMOTION; LOW DRUG DOSE; MALE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SENSITIZATION; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; STRAIN DIFFERENCE; TREATMENT RESPONSE; WISTAR KYOTO RAT;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; SPECIES SPECIFICITY;

EID: 80052866606     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.08.027     Document Type: Article

References (74)

1. Goldman L.S., Genel M., Bezman R.J., Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998, 279:1100-1107.
2. Wilens T.E., Adler L.A., Adams J., Sgambati S., Rotrosen J., Sawtelle R., et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008, 47:21-31.
3. Faraone S.V., Wilens T.E. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry 2007, 11:15-22.
4. LeFever G.B., Dawson K.V., Morrow A.L. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health 1999, 89:1359-1364.
5. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jensen P.S., Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998, 351:429-433.
6. Landgren M., Kjellman B., Gillberg C. Deficits in attention, motor control and perception (DAMP): a simplified school entry examination. Acta Paediatr 2000, 89:302-309.
7. Castellanos F.X., Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002, 3:617-628.
8. Vendruscolo L.F., Izídio G.S., Takahashi R.N., Ramos A. Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats. Behav Pharmacol 2008, 19:21-27.
9. Dafny N., Yang P.B. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull 2006, 68:393-405.
10. Levin F.R., Kleber D.H. Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv Rev Psychiatry 1995, 2:246-258.
11. Moll G.H., Hause S., Rüther E., Rothenberger A., Huether G. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adolesc Psychopharmacol 2001, 11:15-24.
12. Brandon C.L., Marinelli M., Baker L.K., White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 2001, 25:651-661.
13. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000, 283:1025-1030.
14. Cornforth C., Sonuga-Barke E., Coghill D. Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients. Curr Pharm Des 2010, 16:2424-2433.
15. Anderson J.C., Williams S., McGee R., Silva P.A. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry 1987, 44:69-76.
16. Biederman J., Faraone S.V., Spencer T., Wilens T., Mick E., Lapey K.A. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 1994, 53:13-29.
17. Berger D.F., Sagvolden T. Sex differences in operant discrimination behavior in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 1998, 94:73-82.
18. Camp D.M., Robinson T.E. Susceptibility to sensitization. I. Sex differences in the enduring effects of chronic d-amphetamine treatment on locomotion, stereotyped behavior and brain monoamines. Behav Brain Res 1988, 30:55-68.
19. Robinson T.E. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berl) 1984, 84:466-475.
20. Askenasy E.P., Taber K.H., Yang P.B., Dafny N. Methylphenidate (Ritalin): behavioral studies in the rat. Int J Neurosci 2007, 117:757-794.
21. Volkow N.D., Wang G.J., Fowler J.S., Ding Y.S. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1410-1415.
22. Challman T.D., Lipsky J.J. Methylphenidate: its pharmacology and uses. Mayo Clin Proc 2000, 75:711-721.
23. Gatley S.J., Volkow N.D., Gifford A.N., Fowler J.S., Dewey S.L., Ding Y.S., et al. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology (Berl) 1999, 146:93-100.
24. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 1998, 94:127-152.
25. Torres-Reveron A., Dow-Edwards D.L. Prenatal cocaine dampened behavioral responses to methylphenidate in male and female adolescent rats. Neurotoxicol Teratol 2006, 28:165-172.
26. Brenhouse H.C., Napierata L., Kussmaul L., Leussis M., Andersen S.L. Juvenile methylphenidate exposure and factors that influence incentive processing. Dev Neurosci 2009, 31(1-2):95-106.
27. Beckman D.A., Schneider M., Youreneff M., Tse F.L. Juvenile toxicity assessment of d,l-methylphenidate in rats. Birth Defects Res B Dev Reprod Toxicol 2008, 83:48-67.
28. Teo S., Stirling D., Thomas S., Hoberman A., Kiorpes A., Khetani V. A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in Sprague-Dawley rats. Toxicology 2002, 179:183-196.
29. Wagner A.K., Kline A.E., Ren D., Willard L.A., Wenger M.K., Zafonte R.D., et al. Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury. Behav Brain Res 2007, 181:200-209.
30. Algahim M.F., Yang P.B., Wilcox V.T., Burau K.D., Swann A.C., Dafny N. Prolonged methylphenidate treatment alters the behavioral diurnal activity pattern of adult male Sprague-Dawley rats. Pharmacol Biochem Behav 2009, 92:93-99.
31. Lee M.J., Yang P.B., Wilcox V.T., Burau K.D., Swann A.C., Dafny N. Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats?. Neuropharmacology 2009, 2(57):1-207.
32. McCarty R., Kopin I.J. Patterns of behavioral development in spontaneously hypertensive rats and Wistar-Kyoto normotensive controls. Dev Psychobiol 1979, 12:239-243.
33. Pires V.A., Pamplona F.A., Pandolfo P., Fernandes D., Prediger R.D., Takahashi R.N. Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder. Behav Pharmacol 2009, 20:134-145.
34. Roessner V., Sagvolden T., Dasbanerjee T., Middleton F.A., Faraone S.V., Walaas S.I., et al. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type. Neuroscience 2010, 167:1183-1191.
35. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 2000, 24:31-39.
36. Thanos P.K., Ivanov I., Robinson J.K., Michaelides M., Wang G.J., Swanson J.M., et al. Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task. Pharmacol Biochem Behav 2010, 94:374-379.
37. Simchon Y., Weizman A., Rehavi M. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD. Eur Neuropsychopharmacol 2010, 10:714-720.
38. Benet L.Z., Kroetz D.L., Sheiner L.B. Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. The pharmacological basis of therapeutics 1996, 11. McGraw Hill, N.Y. 9th ed. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Gilman (Eds.).
39. Bolanos C.A., Glatt S.J., Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Brain Res Dev Brain Res 1998, 111:25-33.
40. Campbell J.O., Wood R.D., Spear L.P. Cocaine and morphine-induced place conditioning in adolescent and adult rats. Physiol Behav 2000, 68:487-493.
41. Collins S.L., Montano R., Izenwasser S. Nicotine treatment produces persistent increases in amphetamine-stimulated locomotor activity in periadolescent male but not female or adult male rats. Dev Brain Res 2004, 153:175-187.
42. Laviola G., Wood R.D., Kuhn C., Francis R., Spear L.P. Cocaine sensitization in periadolescent and adult rats. J Pharmacol Exp Ther 1995, 275:345-357.
43. McDougall S.A., Collins R.L., Karper P.E., Watson J.B., Crawford C.A. Effects of repeated methylphenidate treatment in the young rat: sensitization of both locomotor activity and stereotyped sniffing. Exp Clin Psychopharmacol 1999, 7:208-218.
44. Rezvani A.H., Levin E.D. Adolescent and adult rats respond differently to nicotine and alcohol: motor activity and body temperature. Int J Dev Neurosci 2004, 22:349-354.
45. Roffman J.L., Raskin L.A. Stereotyped behavior: effects of d-amphetamine and methylphenidate in the young rat. Pharmacol Biochem Behav 1997, 58:1095-1102.
46. Gaytan O., Yang P., Swann A., Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Res 2000, 864:24-39.
47. Barron E., Yang P.B., Swan A.C., Dafny N. Adolescent and adult male spontaneous hyperactive rats (SHR) respond differently to acute and chronic methylphenidate (Ritalin). Int J Neurosci 2009, 119:40-58.
48. Lee M.J., Swann A.C., Dafny N. Methylphenidate sensitization is prevented by prefrontal cortex lesion. Brain Res Bull 2008, 76:131-140.
49. Yang P., Singhal N., Modi G., Swann A., Dafny N. Effects of lithium chloride on induction and expression of methylphenidate sensitization. Eur J Pharmacol 2001, 426:65-72.
50. Yang P.B., Swann A.C., Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res Bull 2006, 71:301-310.
51. Yang P.B., Swann A.C., Dafny N. Psychostimulants given in adolescents modulate their effects in adulthood using the open field and the wheel-running assays. Brain Res Bull 2010, 82:208-217.
52. Yang P.B., Amini B., Swann A.C., Dafny N. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res 2003, 971:139-152.
53. Wilens T.E., Faraone S.V., Biederman J., Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179-185.
54. Greely H., Sahakian B., Harris J., Kessler R.C., Gazzaniga M., Campbell P., et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008, 456:702-705.
55. Yang P.B., Swann A.C., Dafny N. Methylphenidate treated at the test cage-dose-dependent sensitization or tolerance depend on the behavioral assay used. Crit Rev Neurobiol 2007, 19:59-77.
56. Eichlseder, Ten W. years of experience with 1,000 hyperactive children in a private practice. Pediatrics 1985, 76:176-184.
57. Gadow K.D. An overview of three decades of research in pediatric psychopharmacoepidemiology. J Child Adolesc Psychopharmacol 1997, 7:219-236. [Review].
58. Pelham W.E., Gnagy E.M., Burrows-Maclean L., Williams A., Fabiano G.A., Morrisey S.M., et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 2001, 107:1-15.
59. White S.R., Yadao C.M. Characterization of methylphenidate exposures reported to a regional poison control center. Arch Pediatr Adolesc Med 2000, 154:1199-1203.
60. El-Zein R.A., Abdel-Rahman S.Z., Hay M.J., Lopez M.S., Bondy M.L., Morris D.L., et al. Cytogenetic effects in children treated with methylphenidate. Cancer Lett 2005, 230:284-291.
61. Kollins S.H., MacDonald E.K., Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 2001, 68:611-627. [Review].
62. Rush C.R., Baker R.W. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol 2001, 9:59-73.
63. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 1993, 4:289-312.
64. Santosh P.J., Taylor E. Stimulant drugs. Eur Child Adolesc Psychiatry 2000, 9(Suppl. 1):I27-I43. [Review].
65. Valvassori S.S., Frey B.N., Martins M.R., Réus G.Z., Schimidtz F., Inácio C.G., et al. Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behav Pharmacol 2007, 18:205-212.
66. Ferguson S.A., Cada A.M. A longitudinal study of short- and long-term activity levels in male and female spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rats. Behav Neurosci 2003, 117:271-282.
67. Wooters T.E., Dwoskin L.P., Bardo M.T. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berl) 2006, 188:18-27.
68. Ernst M., Liebenauer L.L., King A.C., Fitzgerald G.A., Cohen R.M., Zametkin A.J. Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994, 33:858-868.
69. Pauls D.L. Genetic factors in the expression of attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 1991, 1:353-360.
70. Andersen S.L., Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev 2000, 24:137-141.
71. Sagvolden T., Pettersen M.B. Spontaneously hypertensive rat (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol Behav 1993, 54:1047-1055.
72. Sagvolden T., Sergeant J.A. Attention deficit/hyperactivity disorder-from brain dysfunctions to behaviour. Behav Brain Res 1998, 94:1-10.
73. Sripada S., Gaytan O., Al-rahim S., Swann A., Dafny N. Dose-related effects of MK-801 on acute and chronic methylphenidate administration. Brain Res 1998, 814:78-85.
74. Ferguson S.A., Paule M.G., Cada A., Fogle C.M., Gray E.P., Berry K.J. Baseline behavior, but not sensitivity to stimulant drugs, differs among spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rat strains. Neurotoxicol Teratol 2007, 29:547-561.